Baskin Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-810
| Closed | -$26K | – | 48 |
|
|
2017
Q1 | $26K | Sell |
810
-90,745
| -99% | -$2.91M | 0.01% | 46 |
|
|
2016
Q4 | $3.32M | Sell |
91,555
-2,758
| -3% | -$100K | 0.82% | 37 |
|
|
2016
Q3 | $4.34M | Buy |
94,313
+2,618
| +3% | +$120K | 1.14% | 34 |
|
|
2016
Q2 | $4.6M | Buy |
91,695
+1,275
| +1% | +$64K | 1.3% | 33 |
|
|
2016
Q1 | $4.84M | Buy |
90,420
+2,560
| +3% | +$137K | 1.4% | 33 |
|
|
2015
Q4 | $5.77M | Buy |
87,860
+1,100
| +1% | +$72.2K | 1.78% | 30 |
|
|
2015
Q3 | $4.9M | Sell |
86,760
-1,475
| -2% | -$83.3K | 1.66% | 32 |
|
|
2015
Q2 | $5.22M | Buy |
88,235
+1,550
| +2% | +$91.6K | 1.63% | 33 |
|
|
2015
Q1 | $5.4M | Buy |
86,685
+3,365
| +4% | +$210K | 1.8% | 32 |
|
|
2014
Q4 | $4.79M | Buy |
83,320
+1,775
| +2% | +$102K | 1.55% | 34 |
|
|
2014
Q3 | $4.38M | Buy |
81,545
+850
| +1% | +$45.7K | 1.52% | 33 |
|
|
2014
Q2 | $4.23M | Buy |
80,695
+5,175
| +7% | +$271K | 1.47% | 33 |
|
|
2014
Q1 | $3.99M | Buy |
75,520
+175
| +0.2% | +$9.25K | 1.53% | 33 |
|
|
2013
Q4 | $3.02M | Sell |
75,345
-2,825
| -4% | -$113K | 1.22% | 32 |
|
|
2013
Q3 | $2.95M | Buy |
78,170
+8,000
| +11% | +$301K | 1.41% | 30 |
|
|
2013
Q2 | $2.74M | Buy |
+70,170
| New | +$2.74M | 1.51% | 30 |
|